DEVELOPMENT OF TARGETED NANOPARTICLE DRUG DELIVERY FOR SURGICAL CANCER THERAPY: EFFECTS ON PHARMACOKINETICS, TUMOR ACCUMULATION, THERAPEUTIC EFFICACY, AND SYSTEMIC TOXICITY. Biosci. Insights. 2026;3(02):854-864. Accessed November 10, 2026. https://biosciinsights.com/index.php/BI/article/view/133